StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval
August 10, 2016 12:50 PM
Below is the FDA's approval letter Heron Therapeutics' (Nasdaq:
HRTX
) SUSTOL:
Categories
FDA
Insiders' Blog
Next Articles
FDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst
August 10, 2016 11:14 AM
Pre-Open Stock Movers 08/10: (CLNE) (OCN) (HRTX) (YELP) Higher; (GEVO) (SPWR) (MYGN) (PRGO) Lower (more...)
August 10, 2016 9:28 AM
Form 8-K HERON THERAPEUTICS, INC. For: Aug 09
August 10, 2016 8:43 AM
Heron Therapeutics (HRTX) Reports FDA Approval of SUSTOL
August 10, 2016 8:33 AM
Heron Therapeutics Announces U.S. FDA Approval of SUSTOL® (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting
August 10, 2016 8:30 AM
Heron Therapeutics (HRTX) Halted, News Pending
August 10, 2016 8:25 AM
